Jennifer Boer

1PUBLICATIONS
6CO-AUTHORS
Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Nov 05, 2024
Cost-Effectiveness of Pembrolizumab as First-Line Treatment in Patients with Persistent, Recurrent, or Metastatic Cervical Cancer in the United States.

Bradley J Monk, Sophie van Mens, Oliver Hale

Pageof 1

Frequent Collaborators

1 joint publications

Bradley J Monk

1 joint publications

Oliver Hale

1 joint publications

Frank van Hees

1 joint publications

Shilpi Swami